ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,832Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 95

$880K Total Retail Price of All Prescriptions

Rank: 12 out of 95

552 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 6,740 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $123 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LANTUS 492 423 1 6
SYNTHROID 372 267 2 4
METFORMIN HCL 362 288 3 2
NOVOLOG FLEXPEN 329 239 4 10
SIMVASTATIN 308 230 5 8
PEN NEEDLE 283 205 6 3
NOVOLOG 276 231 7 14
LANTUS SOLOSTAR 274 165 8 5
HUMALOG 263 197 9 11
PRAVASTATIN SODIUM 252 206 10 18
LISINOPRIL 251 174 11 12
AMLODIPINE BESYLATE 237 188 12 15
INSULIN SYRINGE 228 188 13 9
LEVOTHYROXINE SODIUM 226 131 14 1
ALENDRONATE SODIUM 203 169 15 33
FUROSEMIDE 163 112 16 19
POTASSIUM CHLORIDE 152 93 17 31
ATORVASTATIN CALCIUM 149 117 18 17
GABAPENTIN 142 92 19 28
ALLOPURINOL 115 113 20 56
METOPROLOL SUCCINATE 104 88 21 32
METOPROLOL TARTRATE 103 84 22 38
CARVEDILOL 98 72 23 30
GLIMEPIRIDE 94 79 24 7
LOSARTAN POTASSIUM 92 77 25 29
LEVEMIR FLEXPEN 77 69 26 22
LOSARTAN-HYDROCHLOROTHIAZIDE 72 61 27 115
HYDRALAZINE HCL 71 53 28 111
CALCITRIOL 71 69 28 151
HYDROCHLOROTHIAZIDE 68 57 30 24
OMEPRAZOLE 68 50 30 25
FENOFIBRATE 66 49 32 40
METOCLOPRAMIDE HCL 62 50 33 118
ENALAPRIL MALEATE 60 54 34 76
NIASPAN 56 50 35 71
LOVASTATIN 52 39 36 53
LEVOXYL 51 41 37 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.